Skip to content

Welcome to Discover Pharma! Today is : November 12, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Discovery & Development

  • Advanced Therapies,Digital & Data,Drug Discovery & Development

    Alchemab strikes $415m licensing deal with Lilly for ALS candidate ATLX-1282

    UK-based Alchemab Therapeutics has signed a landmark licensing agreement with [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Opinion & Events

    Patient priorities must shape trial design, says One2Treat lead

    To mark Clinical Trials Day, Discover Pharma speaks with Tom [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development

    Why rare disease trials are poised to transform drug development by 2030

    Today on Clinical Trials Day, we spotlight the evolving landscape [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Opinion & Events

    Fixing the gender gap in clinical trials

    Dr Anita Phung, GP and medical monitor at Lindus Health, [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    Yseop on FDA’s AI push: Why structured, explainable content is the future of regulatory submissions

    As the FDA accelerates its use of generative AI in [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain

    Abzena forms Scientific Advisory Board to guide innovation in complex biologics

    Abzena, an integrated CDMO and CRO specializing in complex biologics [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Opinion & Events

    START’s early-phase network supports first-in-human cancer immunotherapy trial targeting solid tumors

    The START Center for Cancer Research has dosed the first [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Opinion & Events

    Phesi analysis reveals colorectal cancer has highest volume of real-world data — but oncology trials remain outdated

    A new analysis by clinical data analytics firm Phesi reveals [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development

    Kaerus receives dual FDA designations for lead Fragile X candidate

    Kaerus Bioscience has been granted Orphan Drug Designation and Rare [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development

    FDA fast-tracks generative AI rollout following successful scientific review pilot

    The US Food and Drug Administration (FDA) has announced plans [...]

    May 5, 2026
Previous757677Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Omniflex deploys cold chain monitoring system across 17 South African research sites
    Categories: Digital & Data, Manufacturing & Supply Chain, Research & Development
  • EMA accepts Almirall application to extend Ebglyss use in young children with atopic dermatitis
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Ten-year NHS study supports focal therapy for prostate cancer with fewer side effects
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top